Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 11/20 | 0.64 |
| ▸ | LPL | P06858 | 10/20 | 0.64 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.38 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.37 |
| ▸ | KDR | P35968 | 1/20 | 0.37 |
| ▸ | P4HB | P07237 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.34 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21693390 | 0.93 | LIPG (0.59) | LIPGLPLDGAT1PDK2PDGFRB | |
| SCHEMBL12781865 | 0.93 | LIPG (0.56) | LIPGLPLDGAT1CA1CA2 | |
| SCHEMBL1753517 | 0.93 | LIPG (0.50) | LIPGLPLDGAT1CA1CA2 | |
| SCHEMBL15603770 | 0.92 | LIPG (0.60) | LIPGLPLDGAT1PDK2PDGFRB | |
| SCHEMBL431646 | 0.91 | LIPG (0.51) | LIPGLPLDGAT1PDK2PDGFRB | |
| SCHEMBL430244 | 0.91 | LIPG (0.51) | LIPGLPLDGAT1PDK2PDGFRB | |
| SCHEMBL70387 | 0.90 | LIPG (0.59) | LIPGLPLDGAT1P4HBCA1 | |
| SCHEMBL1753909 | 0.89 | LIPG (0.59) | LIPGLPLDGAT1PDK2P4HB | |
| SCHEMBL69840 | 0.88 | LIPG (0.50) | LIPGLPLDGAT1PDK2PDGFRB | |
| SCHEMBL12056858 | 0.88 | LIPG (0.70) | LIPGLPLDGAT1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3037398-B1 | METHOD FOR MANUFACTURING CHEMICAL COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2021-03-10 | — | — | EP | disclosed |
| WO-2020111663-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 두산솔루스 주식회사 | 2020-06-04 | — | — | WO | disclosed |
| WO-2020111663-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 두산솔루스 주식회사 | 2020-06-04 | — | — | WO | disclosed |
| US-9982087-B2 | Method for producing compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-29 | — | — | US | disclosed |
| US-9982087-B2 | Method for producing compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-29 | — | — | US | disclosed |
| EP-3225610-A1 | METHOD FOR MANUFACTURING COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2017-10-04 | — | — | EP | disclosed |
| US-20160200861-A1 | METHOD FOR PRODUCING COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-07-14 | — | — | US | disclosed |
| US-20160200861-A1 | METHOD FOR PRODUCING COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-07-14 | — | — | US | disclosed |
| EP-3037398-A1 | METHOD FOR MANUFACTURING CHEMICAL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2016-06-29 | — | — | EP | disclosed |
| US-8841004-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2014-09-23 | — | — | US | disclosed |
| US-8841004-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2014-09-23 | — | — | US | disclosed |
| US-20120061657-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2012-03-15 | — | — | US | disclosed |
| US-20120061657-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2012-03-15 | — | — | US | disclosed |
| US-20110282063-A1 | METHOD OF PRODUCING A DIAZAFLUORENE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2011-11-17 | — | — | US | disclosed |
| US-20110282063-A1 | METHOD OF PRODUCING A DIAZAFLUORENE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2011-11-17 | — | — | US | disclosed |
| US-20080161574-A1 | DIAZAFLUORENE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2008-07-03 | — | — | US | disclosed |
| US-20080161574-A1 | DIAZAFLUORENE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2008-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161574-A1 | DIAZAFLUORENE COMPOUND | AFF1, NPFFR1, AFF2 | LIPG 4352/4885LPL 4328/4885DGAT1 898/4885 |
| US-20110282063-A1 | METHOD OF PRODUCING A DIAZAFLUORENE COMPOUND | AFF1, AFF2, AFF4 | LIPG 4442/4885LPL 4158/4885DGAT1 913/4885 |
| US-20160200861-A1 | METHOD FOR PRODUCING COMPOUND | NUDT1, OSGEP, CNOT9 | LIPG 4765/4885LPL 4513/4885DGAT1 1134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.